Sign inJoin waitlistJoin the waitlist

Elizabeth Sokol

Assistant Professor, Pediatrics · McGaw Medical Center of Northwestern University

Credentials: · · · ·

History

McGaw Medical Center of Northwestern University
Present
McGaw Medical Center of Northwestern University
Present

Pediatric Hematology Oncology
University of Chicago Medical Center
2014–2017
Pediatrics
University of Chicago Medical Center
2011–2014
Hospital
2011–2014
University of Illinois College of Medicine
2007–2011

Research

The Evolution of Risk Classification for Neuroblastoma
Review · Children · 2019 · First of 2 authors · 107 citations
Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2024 · 96 citations
Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project
Journal of Clinical Oncology · 2020 · First of 13 authors · 74 citations

Susan Cohn
9 papers
Ami Desai
7 papers
Mark Applebaum
6 papers
Navin Pinto
6 papers
Rochelle Bagatell
6 papers
Julie Park
4 papers
Hiroyuki Shimada
3 papers
Jennifer Foster
3 papers
Kritika Patel
3 papers
Peter Pytel
3 papers
Rajen Mody
3 papers
Samuel Volchenboum
3 papers

Clinical trials

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2026–2029
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2029
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2024–2029
VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
Site PI · Recruiting · Phase 1, Phase 2
University of Texas Southwestern Medical Center
2023–2027